Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell Carcinoma.

Xie, Guiqin; Shan, Liang; Liu, Yuanyi; Wu, Tzyy-Choou; Gu, Xinbin

Xie, Guiqin; Shan, Liang; Liu, Yuanyi; Wu, Tzyy-Choou; Gu, Xinbin.

Afiliação

Xie G; Department of Oral Pathology and Cancer Center, Howard University, Washington, DC 20059, USA.
Shan L; Cancer Center, Howard University, Washington, DC 20059, USA.
Liu Y; Cancer Center, Howard University, Washington, DC 20059, USA.
Wu TC; Angimmune LLC, Rockville, MD 20855, USA.
Gu X; Pathology, Oncology, Obstetrics & Gynecology and Molecular Microbiology &Immunology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Biology (Basel) ; 11(4)2022 Mar 22.

Article em En | MEDLINE | ID: mdl-35453686

Palavras-chave

EGFR; HNSCC; efficacy; head and neck squamous cell carcinoma; recombinant immunotoxin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Biology (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google